This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) rallied 8.77% to $7.69 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.69% to 4,361.19 and Dow Jones Industrial Average falling 0.72% to 34,496.06. Ocugen Inc. closed $11.08 below its 52-week high ($18.77), which the company reached on February 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Adverum Biotechnologies Inc. (ADVM) fell 0.49% to $2.05, Ocular Therapeutix Inc. (OCUL) rose 15.38% to $11.25, and Kodiak Sciences Inc. (KOD) rose 1.29% to $104.33. Trading volume (13.8 M) eclipsed its 50-day average volume of 12.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 11, 2021.
(END) Dow Jones Newswires
October 11, 2021 17:13 ET (21:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.